Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Turing Pharmaceuticals AG

Latest From Turing Pharmaceuticals AG

Decade In Review: Biopharma's Shifting Legal Landscape

Emergence of the inter partes review process dramatically changed the patent dispute arena.  The decade also brought biosimilar litigation, generic price-fixing complaints, opioid lawsuits and new government investigations and antitrust actions.

Legal Issues Biosimilars

At Paragon, Jeffrey Aronin Has Launched His Next Act – Or Eight Of Them

Jeffrey Aronin, who presided over Marathon Pharmaceuticals during a drug-pricing kerfuffle that drew congressional scrutiny, has built a portfolio of new drug companies at Paragon Biosciences.

StartUps and SMEs Research and Development Strategies

Show Us The Birth Certificate? An Authorless US FDA Import Policy

For two decades it has been almost dogma in the US pharmaceutical industry that no FDA commissioner would sign off on a policy to permit wholesale imports of drugs from Canada. Now that a proposed rule has been issued – it still may be true.

Pricing Debate FDA

Drug Pricing Hearing Takes A Partisan Turn As Gilead’s O’Day Holds His Own

Republicans took off the gloves at House oversight hearing on PrEP, arguing Democrats are more interested in scoring political points than seeking policy solutions to high drug costs.
Pricing Debate Legislation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Turing Pharmaceuticals LLC
  • Turing Pharmaceuticals LLC
  • Turing Pharmaceuticals LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Turing Pharmaceuticals AG
  • Senior Management
  • Ron Tilles, Interim CEO
    Nancy Retzlaff, Chief Commercial Officer
    Eliseo Oreste Salinas, MD, Pres., R&D
  • Contact Info
  • Turing Pharmaceuticals AG
    Phone: 41 760 24 24
    Haldenstrasse 5
    Baar, NY CH-6340